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Abstract 
Conformational changes associated to sensing mechanisms of heme-based protein 
sensors are a key molecular event that seems to modulate not only the protein activity 
but also the potential of the Fe
III/II
 redox couple of the heme domain. In this work, 
midpoint potentials (Em) assigned to the Fe
III/II
 redox couple of the heme domain of 
FixL from Rhizobium etli (ReFixL) in the unliganded and liganded states were 
determined by spectroelectrochemistry in the presence of inorganic mediators. In 
comparison to the unliganded ReFixL protein (+19 mV), the binding to ligands that 
switch off the kinase activity induces a negative shift, i. e. Em = 51, 57 and 156 mV 
for O2, imidazole and CN

, respectively. Upon binding to CO, which does not affect the 
kinase active, Em was observed at +21 mV. The potential values observed for Fe
III/II
 of 
the heme domain of ReFixL upon binding to CO and O2 do not follow the expected 
trend based on thermodynamics, assuming that positive potential shift would be 
expected for ligands that bind to and therefore stabilize the Fe
II
 state. Our results 
suggest that the conformational changes that switch off kinase activity upon O2 binding 
have knock-on effects to the local environment of the heme, such as solvent 
rearrangement, destabilize the Fe
II
 state and counterbalances the Fe
II
-stabilizing 
influence of the O2 ligand. 
 
 
Keywords: Heme-based sensor, FixL, redox potential, kinase activity, 
spectroelectrochemistry 
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1. Introduction 
During the last two decades, a new family of hemoproteins has emerged with the 
function of biological sensors. Currently, these proteins are called heme-based sensors 
and are ubiquitous in nature; from archae to humans. These sensors have also exhibited 
many distinct biological functions, such as regulators of nitrogen fixation, aerotaxis, 
dormancy, circadian rhythms, among others [1-4]. Interestingly, these proteins harbour 
the heme group in at least 7 different types of fold, e.g. PAS, Globin, CooA, HNOB, 
GAF, SCHIC, LDB, which are usually coupled to a variety of output domains, 
including domains that exhibit enzymatic activity, DNA-protein or protein-protein 
interaction properties under ON/OFF control by the axial ligands bound to the heme 
domain [2, 3], as schematically illustrated in Fig. 1.  
 
Fig. 1. General Scheme of Heme-Based Sensor Regulation 
In 1991, a landmark publication reported that FixL was an oxygen heme-based 
sensor [5]. Since then, FixL has been one of the most thoroughly investigated heme-
based sensors, with many of its mechanistic details elucidated [6-14]. Commonly found 
in bacteria, FixL is part of a two-component system in which it acts as a sensor kinase 
while the transcription factor FixJ acts as a response regulator protein [15]. While the 
kinase activity of FixL is switched off upon binding to O2 [8, 16], under anaerobiosis a 
FixL histidine residue is autophosphorylated. Subsequent transfer of the histidine 
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phosphoryl group to an aspartate residue in the N-terminal signaling domain of FixJ 
makes the transcriptionally active phospho-FixJ, which then induces the expression of 
nitrogen fixation and microaerobic respiration genes (fix and nif genes) [3]. 
FixL from Bradyrhizobium japonicum (BjFixL) and Sinorhizobium meliloti 
(RmFixL) have been widely studied over recent years and, despite the fact that these 
FixLs are quite similar (see sequence alignment in Fig. S1 of the Supplementary 
Material), there are some differences in their domain organization and heme-regulated 
properties [6-10, 12-14]. For example, BjFixL can catalyse FixJ phosphorylation either 
in the deoxy (Fe
II
) or met (Fe
III
) state, while oxy (Fe
II
-O2) and cyano-met (Fe
III
-CN

) 
states efficiently deactivate BjFixL. On the other hand, RmFixL is only fully active in 
the deoxy (Fe
II
) state, while met (Fe
III
), oxy (Fe
II
-O2) and cyano-met (Fe
III
-CN

) states 
are kinase inactive towards FixJ turnover. Recently, another interesting FixL from 
Rhizobium etli (ReFixL) was investigated [11]. This is a hybrid sensor kinase that 
contains, additionally to BjFixL domains, a FixJ-like receiver domain at the C-terminal. 
This system promotes histidine phosphorylation and phosphoryl transfer to aspartate in 
the same protein, which facilitates investigation of all of these regulatory phenomena in 
one protein. Similarly to BjFixL, ReFixL contains two PAS domains in tandem and is 
fully kinase active in the deoxy (Fe
II
) and met (Fe
III
) states while bound to O2 and CN

, 
the ReFixL protein is no longer active. The heme is bound to the second PAS domain, 
while the first PAS also mediates signal transduction and influences the oxygen affinity 
of the second PAS. ReFixL has the lowest oxygen affinity measured for any heme based 
sensor (Kd = 738 µM) [11].  Nevertheless, the kinase activity of ReFixL is fully 
inhibited when only 26% of the protein is saturated with oxygen; since ReFixL is 
dimeric, cooperativity cannot account for this. The most likely explanation is a 
hysteretic effect similar to the “memory effect” shown for BjFixL [12]. 
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In heme-based sensors, as in all other ligand binding heme proteins, amino acid 
residues in contact with the heme are sensitive to ligand binding. These local structural 
changes and their accompanying effects on reduction potential have been measured for 
some heme based sensors. [17]. For FixL proteins, however, only a few studies on the 
redox potentials have been conducted, and only with isolated heme domains, not the 
full-length protein, which will miss all the effects due to coupling of the heme domain 
changes to the conformational changes in the kinase domain that result in reversible 
inactivation.  [17-20].  These long-range effects of ligand binding are broadly analogous 
to the triggering of the R-T quaternary structure change in hemoglobin caused by ligand 
binding. Such changes must affect the redox potential making the understanding of this 
connection a key step for learning the mechanistic principles of signal transduction.  
In this work we have examined the full-length ReFixL at different liganded 
states and conditions using mediated spectroelectrochemistry, where the protein is 
gradually reduced/oxidized at a constant applied potential and a spectrum is recorded 
for each potential. To ensure equilibrium is established between the electrode and the 
oxidized and reduced forms of FixL small molecular weight redox mediators are present 
as electron relays between the electrode and the protein. 
 
2. Materials and Methods 
2.1. Chemicals 
Aqueous solutions were prepared using Millipore (Germany) water of resistivity 
greater than 18.2 MΩ cm at 25 oC. Tris(hydroxymethyl)aminomethane, sulfuric acid, 
formic acid, acetic acid, imidazole, NaCl, all from Sigma-Aldrich (United States), and 
KCN from Merck (Germany) were used as received.  
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The mediator 2,5-dihydroxybenzoquinone [21] was purchased from Lancaster 
and the following coordination compounds (with their formal Co
III/II
 redox potentials at 
pH 8.0) [Co((NMe3)2sar)]Cl5
 
(+10 mV vs NHE), [Co(CLME-N4S2-sar)]Cl3 (134 mV 
vs NHE), [Co(AMME-N5S-sar)]Cl3 (220 mV vs NHE), [Co(sep)]Cl3 (296 mV vs 
NHE), [Co(AMMEsar)]Cl3 (380 mV vs NHE) and [Co(trans-diammac)](ClO4)3 (551 
mV vs NHE) have been described collectively in earlier publications [22-27].  
2.2. Protein Expression, Purification and Assays 
The full-length Rhizobium etli fixL (ReFixL) gene was cloned in a pUC19 
derived plasmid under a tac promoter regulation, which contained ampicillin resistance 
gene for selection in Escherichia coli strain MC1061(E. coli). The expression and 
purification followed the procedures described in the literature [11]. The purity of the 
protein was evaluated by SDS-PAGE and UV-Vis spectra resulting in > 90%. 
2.3. Spectroelectrochemistry 
Spectroelectrochemistry measurements were performed with a BAS100B/W or 
EPSILON potentiostats (Bioanalytical Systems Inc., BASi, West Lafayettte, IN, USA) 
using an optically transparent thin-layer cell (OTTLE, 0.1mm or 0.05 mm) with a gold 
or platinum mesh working electrode, a platinum wire counter electrode and Ag/AgCl 
reference electrode (+196 mV vs NHE), in conjunction with an Ocean Optics USB2000 
fibre optic UV-Vis spectrophotometer (United States) with the spectroelectrochemistry 
cell mounted inside a Belle Technology anaerobic box (O2 concentration < 20 ppm, 
United Kingdom). For experiments performed in the presence of oxygen the buffer 
solution (35 mM Tris, pH 8.0, 100 mM NaCl) was previously saturated with pure O2 for 
20 min and a constant flux was kept during the titrations. A Cary 5000 UV-Vis-NIR 
(United States) and an Agilent 8453 diode array spectrophotometers (United States) 
were used for the acquisition of the spectra with applied potential. While the 
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measurements in the presence of O2 and CN

 were taken on the former equipment, the 
Agilent spectrophotometer was used for the acquisition of the spectra in air and in the 
presence of CO.  
All potentials, unless otherwise specified, are referenced against a normal 
hydrogen electrode (NHE) at room temperature (25˚C) and the AgǀAgCl/Cl reference 
electrode was always calibrated against the quinhydrone redox couple (+86 mV vs 
AgǀAgCl/Cl at pH 7.0 and 25˚C). 
Typical spectroelectrochemical experiments were run with ca. 15 µM of ReFixL 
in an electrolyte solution of 35 mM Tris buffer (pH 8.0) and 100 mM NaCl. All 
mediators, except 2,5-dihydroxybenzoquinone, which was used only in the anaerobic 
study of ReFixL with no additional ligands, were used at concentrations of ca. 100 µM. 
Prior to the acquisition of the spectra, the working electrode (Au mesh or Pt mesh) was 
polarized at + 0.3 V vs NHE for 8 min to ensure the fully oxidized state of the protein, 
met-ReFixL (Fe
III
-unliganded ReFixL). Typically, the potential was scanned firstly in 
the negative direction and then back in the positive direction to check the reversibility of 
the systems and the existence of hysteresis. A potential range of 0.55 V, usually from 
+0.3 to 0.25V vs NHE, was applied in steps of 0.05V and 0.025V in the vicinity of the 
redox midpoint potential. Each potential was held for at least 8 min before the spectrum 
was taken. All data were treated by global analysis with Reactlab Redox (Australia) [28] 
and kinetic analysis of the spectral changes as a function of time was performed with 
Reactlab Kinetics (Australia) [29]. 
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3. Results  
Aiming to study the redox process of the Rhizobium etli FixL (ReFixL) protein 
in the presence of O2, CO, CN

, and imidazole, a series of spectroelectrochemical 
measurements were conducted using a mixture of the mediators given in the Section 
2.1. The organic mediator 2,5-dihydroxybenzoquinone (60 mV vs NHE) was also used 
in the measurements of ReFixL in deaerated solution to provide additional redox 
buffering at higher potentials. In this work, a mixture of all mediators were used in each 
experiment to provide identical conditions in each case regardless of where the redox 
potential was found in ReFixL. As reported previously [30], relative to the strongly 
absorbing heme chromophore (at a concentration of 15 μM), the Co complex mediators 
are essentially colorless in both oxidation states at the concentrations used (100 μM) as 
so no interference from mediator absorption is found.  
We initially found that experiments in the presence of CN

 carried out with a 
gold working electrode were not reversible as the concentration of CN

 in solution 
decreased during the course of the experiment. This was attributed to the anodic 
formation of [Au(CN)2]

 and thus consumption of the cyanide. This problem was 
averted by using a Pt mesh working electrode as Pt is inert to oxidation in the presence 
of cyanide at the potentials used in the experiment. Also, CN

 is a weak base (pKa 9.2) 
so experiments with this ligand were carried out at pH 9.5 to avoid major protonation 
and loss of volatile HCN from the solution. In order to discuss the data obtained for 
ReFixL-CN

 in relation to the unliganded protein, the spectroelectrochemical 
experiments for the deoxy-ReFixL were also performed at pH 9.5. 
Fig. 2A shows the spectral results for the oxidized (Fe
III
) and reduced (Fe
II
) 
forms of ReFixL in the absence of oxygen. Global analysis of all 
absorbance/wavelength data obtained across all applied potentials (see Figs S2 to S6 in 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
9 
 
the Supplementary Material) yielded the redox midpoint potential of the half reaction 
and also the spectra of the fully oxidized and reduced forms, as shown in Fig. 2. 
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Fig. 2. UV-Vis spectra of the unliganded Fe
III
 (solid black line), Fe
III
-imz and Fe
III
-CN 
(dark gray line), and Fe
II
 (dotted black line) forms of 15 µM ReFixL in electrolyte 
solutions (35 mM Tris buffer (pH 8.0) and 100 mM NaCl) as follows: (A) 
deoxygenated, (B) CO saturated (0.93 mM), (C) oxygen saturated (1.25 mM, at 25 
o
C), 
(D) 200 mM imidazole and (E) 1.0 mM CN

 (pH 9.5). 
In the absence of any additional ligands, the spectra in Fig. 2A are each 
characteristic of the five-coordinate deoxy-Fe
II
 and Fe
III
 states of the ReFixL heme [30]. 
The most pronounced change is in the Soret band, which shifts from 395 nm (Fe
III
) to 
432 nm (Fe
II
). The broad visible absorption band (a combination of the α- and β-bands) 
also shifts to longer wavelength upon reduction (500 nm to 560nm). 
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It is well known that CO is a ligand that binds very well to heme cofactors, 
binding only to the Fe
II
 heme similar to oxygen. We also found this with ReFixL (Fig. 
2B), where an intense and sharp Soret band (426 nm) for the six-coordinate Fe
II
-CO, 
ReFixL-CO, form was identified. Also the α- and β- bands are well resolved as maxima 
at 571 and 542 nm, respectively. As expected the Fe
III
 heme is unaffected by CO and the 
same spectrum of the five-coordinate Fe
III
 heme seen in Figs 2A and 2B is obtained. 
In the presence of oxygen (Fig. 2C) the spectral changes are subtly different. 
Initially the Fe
III
 spectrum is the same as in Fig. 2A as the Fe
III
 heme has no affinity for 
oxygen. However, O2 does bind to the Fe
II
 heme and the spectrum of the oxy-Fe
II
 form 
(Fig. 2C) is clearly different from the deoxy-Fe
II
 state (Fig. 2A). The most significant 
change is the splitting of the single visible region band of deoxy-Fe
II
 (Fig. 2A) into two 
broad peaks at 569 and 554 nm. It should be mentioned that the calculated spectrum of 
the oxy-Fe
II
 form is actually a combination of deoxy-Fe
II
 and oxy-Fe
II
 as the heme 
cofactor has only a weak affinity for dioxygen; i.e. c.a. 26% and 63% oxygen bound in 
air and under O2 saturation, respectively [11]. 
In Fig. 2D, the spectra are in the presence of 200 mM imidazole. The Fe
III
 
spectrum is clearly different from those of the five-coordinated Fe
III
 heme (Figs 2A and 
2B) and indicate that imidazole is coordinated trans to the histidine residue ligand in the 
axial coordination site i.e. a six-coordinated Fe
III
 heme, ReFixL-imz. The Soret band 
sharpens, gains intensity and moves to longer wavelength. By contrast the Fe
II
 spectrum 
is identical to that determined in the absence of any ligands and without oxygen present 
(Fig. 2A), so imidazole is not bound in the Fe
II
 state. 
Cyanide is a very effective ligand that prefers Fe
III
 over Fe
II
 heme. In the 
presence of 1 mM CN

 the Soret band of the Fe
III
 heme in ReFixL shifts immediately 
from 395 nm to 421 nm corresponding to a change from five-coordinate to six-
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coordinate Fe
III
-CN heme, ReFixL-CN. Upon reduction the CN

 ligand is lost (Fig. 2E) 
as the spectrum is again identical to the deoxy-Fe
II
 spectrum seen in Figs 2A and 2D. 
In all cases the spectra were reversible and it did not matter whether the spectra 
were acquired starting from a high (Fe
III
) or low (Fe
II
) potential. The calculated spectra 
were the same and the redox potentials obtained from the reductive or oxidative sweeps 
were identical; i.e. no relevant hysteresis was seen. In principle only the redox potential 
of the deoxy-Fe
III/II
 can be considered a formal potential as there is no change in 
coordination number. All of the redox potentials calculated from the data in Figs 2B-2E 
are electron transfer reactions coupled to chemical reactions, e.g. Fe(III)L + e  
Fe(II) + L (L = CN

 and imz) or Fe(III) + L‟ + e  Fe(II)L‟ (L‟ = O2 and CO). 
These coupled chemical reactions (ligand binding) were fast on the timescale of the 
spectroelectrochemical cell but the determined midpoint potentials (Em) obtained from 
the experiments involving ligand binding to either Fe
III
 or Fe
II
 are necessarily shifted 
from the formal potential. Usually, ligand binding to the Fe
III
 state (but not to the Fe
II
 
state) should result in a negative shift in the redox potential and ligand binding 
exclusively to the Fe
II
 state should result in a positive shift. This was not always seen 
(Table 1) and an explanation of these interesting changes in the redox potentials is 
deferred to the Discussion. 
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Table 1. Midpoint potentials (Em, mV vs NHE), shifts of the liganded Em values in 
relation to the non-bounded ReFixL (Em, mV) and Soret band electronic spectral 
maxima ( in nm and  in mM cm-1) of FeIII and FeII ReFixL in its various liganded 
states.  
Protein 
(a)
Em Em 
Fe
III
 Fe
II
 
ox ɛ red ɛ 
ReFixL +19.0  0.0 395 126.0 432 129.2 
(b)
ReFixL 11 ± 2.8 - 395 126.0 432 129.2 
ReFixL-O2 (air) 12  31.0 395 126.0 428 134.5 
ReFixL-O2 (O2 saturated 
solution) 
51  70.0 395 126.0 426 134.5 
ReFixL-CO +21  2.0 395 126.0 426 201.7 
ReFixL-imz 57  76.0 415 128.4 432 129.2 
(b)
ReFixL-CN 156  145.0(c) 424 148.4 432 129.2 
(a)
Fe(III)L + e  Fe(II) + L (L = CN and imz) or Fe(III) + L‟ + e  Fe(II)L‟ (L‟ = 
O2 and CO). 
(b)
Measurements at pH 9.5. 
(c)∆Em value was calculated based on the Em value 
determined for ReFixL (Em = 11 mV) at pH 9.5. 
 
4. Discussion 
4.1. Optical Spectral Features of ReFixL in its Oxidized and Reduced Forms 
The spectral dependence of the liganded and unliganded ReFixL protein on the 
applied potential always gave series of spectra with well-defined isosbestic points (Figs. 
S2 to S6 of the Supplementary Material) supporting the interchange of only two redox 
active species. The only exception to this was for the oxy-Fe
II
 form of ReFixL which 
was always in equilibrium with its deoxy-Fe
II
 form due to its known weak affinity for 
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oxygen. In fact the calculated spectrum of „oxy-FeII‟ ReFixL is a mixture of both oxy- 
and deoxy-Fe
II
. 
Upon reduction of Fe
III
 to Fe
II
 heme, the Soret maximum of the fully oxidized 
state of ReFixL, met-ReFixL, shifts from 395 to 432 nm (Fig. 2A) while the combined 
maximum of the broad α/β bands shift from 500 to 563 nm, a behavior consistent with 
five coordinate, high-spin, b-type hemes [31, 32]. In oxygen saturated solution (Fig. 
2C), the Soret band presents a similar shift upon reduction. The shape of the band, 
however, is broad and asymmetric supporting partial formation of oxy-ReFixL as 
previously reported [11].  
A hypothetical domain-domain response induced by the binding of small 
molecules to the PAS domain of ReFixL was raised in the literature based on the 
changes in oxygen affinity modulated by the adjacent non-heme-binding PAS domain 
[11]. Similar behavior was reported before for other heme-based sensors [33, 34], where 
oxygen affinity for the heme domains and full-length proteins showed significant 
differences. Full-length BjFixL showed a 4-fold lower oxygen affinity than its isolated 
heme domain, while DosP, an oxygen sensor phosphodiesterase, was 6-fold lower [33, 
34]. These results have highlighted the sensitivity and connectivity of the heme to 
changes also outside of the immediate vicinity of the iron heme, which can occur during 
signal transduction events. Furthermore, these observations reinforce the importance of 
measurements conducted on the full-length protein.  
Such findings lead us to surmise that the redox behavior and, consequently, the 
physiological function of ReFixL is affected by binding other small molecules such as 
CO, imidazole and CN

. Figs 2B, 2D and 2E show the spectral changes of ReFixL with 
applied potential in solution containing CO, imidazole and CN

, respectively. In 
solutions containing imidazole and CN

, the Soret band of the met-ReFixL shifts to 415 
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nm and 424 nm (Figs. 2D and 2E), respectively, indicating binding to Fe
III
. On the other 
hand, no shift is observed in the spectra of met-ReFixL in the CO saturated medium 
(Fig. 2B). In the presence of CO, the Soret band of the Fe
II
 form shifts to 426 nm along 
with a concomitant shape change to a sharp and very intense peak. This is corroborated 
by clear separation of the α- and β-band maxima which also indicates the CO 
coordination in the sixth site; features characteristic of low spin Fe
II
 heme b 
chromophores. In the imidazole and cyanide experiments, the oxidative scan leads to the 
recovery of the non-CO-coordinated form.  
4.2. Ligand Dependent Shifts in Redox Potential 
For discussion purpose, Table 2 displays the Em values for the systems studied in 
this work along with those reported in the literature for some sensor and non-sensor 
heme-based proteins. 
Table 2. Redox potentials of sensor and non-sensor heme-based proteins. 
Heme protein Em, mV Reference 
PAS domain 
ReFixL +19 This work 
ReFixL* 11 This work 
ReFixL-O2 (air) 12 This work 
ReFixL-O2 (O2 saturated solution) 51 This work 
ReFixL-CO +21 This work 
ReFixL-imz 57 This work 
ReFixL-CN* 156 This work 
[18] 
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  [19, 35, 36] 
Globin domain 
DosC (YddV) (Globin) 22 [20] 
HNOB domain 
[37] 
[38] 
Cyt c domain 
 [39] 
 [40] 
 [40] 
Non-sensor heme proteins 
Myoglobin 46 [41] 
Myoglobin – CN 385 [41] 
 41 [42] 
– CO +8 [42] 
– O2 +9 [42] 
283  [43] 
– 0.0 [43] 
-139 [44] 
– -176 [44] 
– imz -203 [44] 
*Measurements at pH 9.5 
The unliganded ReFixL presents a Fe
III/II
 redox potential significantly lower than 
BjFixL (+68 mV) and DosP (+67 mV), where the heme is also harbored in a PAS 
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domain. It is worth mention that, like BjFixL, the unliganded ReFixL is kinase active in 
both iron states (Fe
II
 and Fe
III
) [11]. 
The significant negative shifts of the redox potentials (Em, Table 1) in the 
presence of imidazole and CN

 are consistent with thermodynamic predictions, where 
ligand binding to the higher oxidation state more tightly than the lower oxidation state 
elicits a negative shift in the observed midpoint potential; the shift being related to the 
relative ligand binding constants in the oxidized and reduced states. The larger shift in 
the cyanide experiment (ΔEm 145 mV) compared with imidazole (ΔEm 76 mV) 
reflects a greater (almost hundred-fold) Fe
III
-CN binding constant than with imidazole. 
It should be addressed that the ΔEm value of ReFixL-CN

 was calculated based on the 
Em values determined for both ReFixL-CN

 and ReFixL (Em = 11 mV) at pH 9.5.  In 
fact, CN

 ligand showed much larger affinity (over 100-fold) than imidazole to BjFixL 
and RmFixL [7, 43], whose trend is followed by ReFixL as indicated by the reported kon 
rates [11]. 
Following the reasoning above, the coordination of ligands high in the 
spectrochemical series (CO, CN

, imidazole) to the lower oxidation state, on the other 
hand, would result in positive potential shift due to thermodynamic stabilization of the 
Fe
II
 states of the protein. Cytochrome P450 CYP2C9 (Fe
II
), for instance, upon binding 
to CO shows a positive shift of 49 mV relative to the non-CO bound protein [42]. 
Another small peptide model of hemoproteins, called peptide-sandwiched mesoheme 
(PSM), exhibits an even larger potential shift (c.a. 283 mV) upon binding to CO [44]. 
Contrary to such thermodynamic predictions, for the ReFixL protein, CO does not alter 
the midpoint potential of the heme significantly from the unliganded form (ΔEm +2 
mV). A similar observation was found for the spectroelectrochemical experiment 
performed in the presence of O2. Oxygen binding exclusively to the Fe
II
 heme should 
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also elicit a positive shift in the Fe
III/II
 redox potential but the opposite was found (ΔEm 
70 mV). Furthermore, the actual shift is almost certainly underestimated as the oxygen 
binding was incomplete. In fact, in air, where only 26% of oxygen bound is reported 
[11], the value of Em was observed at 12 mV with a potential shift of 31 mV in 
relation to deoxy-ReFixL (Fig. S7 of the Supplementary Material). 
4.3. Structural Changes Upon Ligand Binding 
There are clearly other effects at play that counterbalance the ligand-binding 
positive shifts in Fe
III/II
 redox potential for CO and O2. There are reports of redox 
potential changes upon ligand binding that do not involve coordination to the metal 
center but instead induce a conformational change in the protein. Soluble guanylate 
cyclase from Manduca sexta showed a consistent positive shift of +22 mV upon binding 
to YC-1, an allosteric effect that affects heme regulation but does not bind to the iron 
[37]. As mentioned above, modifications to the protein secondary structure may have 
knock-on effects to the local environment of the heme that lead to different second 
sphere interactions at the active site, i.e. ligand binding has indirect effect on the protein 
structure. We suggest that similar events may occur here. Despite the lack of full-length 
X-ray structure for FixL, there is a variety of heme domain structures published for 
FixL from Sinorhizobium meliloti and Bradyrhizobium japonicum in the Fe
II
 unliganded 
(Fe
II
), carbonyl (Fe
II
-CO), and nitrosyl (Fe
II
-NO) in addition to the Fe
III
 unliganded 
(Fe
III
), cyano (Fe
III
-CN

) and imidazole (Fe
III
-imz) bound forms [14, 46-50]. We have 
focused on the most relevant amino acids (within 7 Å of the Fe atom) as shown in Figs 3 
and 4. The CO-bound BjFixL protein has been crystallized in three different space 
groups R32 (one independent molecule in the asymmetric unit), C2 (2 independent 
molecules) and P1 (four independent molecules); so there are 7 independent structures 
of the heme active site. Fig. 3A shows one of these 7 CO-bound structures and three 
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hydrophobic residues (Ile215, Ile238 and Leu236) are highlighted. These alkyl side 
chains have conformational flexibility but in the case of CO-bound BjFixL, remarkably, 
6 of the 7 heme structures bear different conformational combinations of these three 
hydrophobic residues. This reveals a large degree of conformational flexibility at the 
active site of CO-bound BjFixL and uncertainty in the actual solution structure. By 
contrast the Fe
III
 heme structure of BjFixL is more rigid; 5 independent heme domains 
have been structurally characterized and 4 of them are found in the conformation shown 
in Fig. 3B. If these structures can be taken to be representative of solution behavior then 
there is a large conformational rearrangement of the hydrophobic Ile and Leu residues 
upon oxidation of the Fe
II
-CO form to met-Fe
III
. Such changes may be correlated with 
solvent rearrangement at the active site that stabilizes the Fe
III
 form and counterbalances 
the Fe
II
-stabilizing influence of the CO ligand. An overlay view of the X-ray structures 
of the heme domains is shown in Fig. S8 of the Supplementary Material, where the 
conformational changes can be better visualized. 
 
 
(A) (B)
  A 
(C) (D) 
Ile215 
Leu236 
Ile215 
Leu236 
Arg220 
Arg220 
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Fig. 3. Crystal structures of BjFixL (A) in one of its CO-bound forms (PDB 1XJ2), (B) 
in its Fe
III
 unliganded state (PDB 2VV6), (C) in its O2-bound forms (PDB 1DP6) and 
(D) in its Fe
III
 CN

 bound state (PDB 1LT0). 
The conformational change in BjFixL upon oxygen binding is even more 
dramatic. As shown in Fig. 3(C), O2 binding is accompanied by appearance of an 
arginine residue (Arg220) that is in H-bonding contact with the dioxygen ligand. The 
movement of Arg220 has an even more significant effect on the secondary structure of 
the protein. Taking a wider view of the structure (Fig. 4), in the absence of dioxygen as 
a ligand, Arg220 swings away from the heme pocket and H-bonds to a heme propionate 
and a number of other H-bonding interactions are disturbed. This Arg220 was showed 
to play a key role not only in ligand binding, but also critically on signal transduction 
along with Arg206. These interactions cause heme distortion and affect heme 
propionate, which has also been noticed in other heme-based sensor signal transduction 
event [17]. Distal hydrophobic residues Leu and Ile, previously described, have also a 
role as steric residues implicated in the signal transduction as reported elsewhere [48], 
which might have an important role particularly upon imidazole binding.  
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Fig. 4. X-ray crystal structures of the heme domain of BjFixL in the (A) Fe
III
 form 
(PDB 1DRM), (B) Fe
II
 deoxy form (PDB 1LSW), (C) Fe
II
 oxy form (PDB 1DP6), (D) 
Fe
III
 cyanide bound form (PDB 1LT0) and (E) Fe
III
 imidazole bound form (PDB 1DP9) 
illustrating the changes in protein conformation upon O2, cyanide and imidazole 
binding. Inset: superimposed structures of Fe
II
 oxy (blue) and deoxy (grey) BjFixL. 
 
As expected, the same inactive site conformation has been observed in the Fe
III
 
cyanide-bound form of BjFixL where the arginine H-bonds with the cyanide ligand 
(Fig. 4) [47]. It is known that both the oxy and cyanide bound forms of ReFixL are 
switched off with respect to kinase activity. Accounting for all the crystal structures 
determined for liganded BjFixL with species relevant to this study, those structures 
reported for imidazole, O2 and CN

 ligands exhibit the largest conformational changes 
[47]. 
Our results support that electronic properties of the heme are not only dependent 
on the immediate sixth ligand, but a combination of effects including heme distortion, 
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nature of microenvironment, propionate ionic interactions, among other effects (steric 
side chain) as previously suggested by the literature [2, 51, 52]. In summary, there is an 
overall change upon oxygen binding/release involving FG-loop movement that cause 
heme to be flatten and movement of hydrophobic distal residues (Ile215, Ile238) along 
with reorganization of polar residues (especially Arg220). All of these effects counteract 
the intrinsic positive shift in redox potential upon oxygen binding to Fe
II
. 
4.4. Electrochemical Potential Trend and Kinase Activity 
The key process for FixL to work as a heme-based sensor is to bind and 
recognize selectively a given signal. ReFixL in the Fe
II
 state binds very well CO and 
NO, but none of them can alter histidine kinase activity of this protein [11]. Upon 
oxygen binding, the histidine kinase activity is switched off, which is due to structural 
changes started at the heme domain (Fig. 4). On the other hand, ReFixL in the Fe
III
 state 
presents histidine kinase activity, which is likely due to structural similarity of the heme 
domain of the Fe
II
 state as indicated in Fig. 4 by the X-ray structures of FixLs. In the 
Fe
III
 state, also, ReFixL can be switched off upon binding to CN

 and imidazole, which 
is in agreement to structural changes noticed at the heme domain. By correlating the 
histidine kinase activity with the reported overall structural changes of FixL in 
unliganded and liganded states [47], one can hypothesize the dependence of the 
electrochemical potentials on the activity of the protein. Having this in mind the terms 
“ON” and “OFF” in Fig. 5 are related to the kinase activity of the proteins studied in 
this work. Such evidence is quite interesting because, in certain cases, the 
electrochemical potential trend does not follow the expected ligand effect on heme, 
reinforcing other changes taking place to modulate the potential.  
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Fig. 5. Bar plot showing the correlation between histidine kinase activity and Fe
III/II
 
redox potentials of liganded and unliganded ReFixL.  
As can be ascertained from Fig. 5, histidine kinase activity is active when the 
protein shows positive (and quite similar) potentials, i.e. for the unliganded ReFixL and 
ReFixL-CO. For ReFixL-O2, ReFixL-CN

 and ReFixL-imz, whose potentials are all 
negative, the histidine kinase is switched off. 
 
 
 
5. Conclusions 
Spectroelectrochemical studies were performed for the unliganded ReFixL 
protein and upon binding to O2, imidazole, CN

 and CO ligands, knowing that the 
binding of the first three species switches off the kinase activity of ReFixL. In 
comparison to the unliganded ReFixL protein (Em = +19 mV), the binding to the ligands 
that switch off the protein induces a negative shift of the midpoint potential (Em), i. e. 
Em = 51 mV, 57 mV and 156 mV for O2, imidazole and CN

, respectively. Upon 
binding to CO, which does not affect the kinase active, the midpoint potential is 
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observed at +21 mV. The spectral profiles obtained during applying potential also 
showed that imidazole and CN

 bind Fe
III
 while O2 and CO coordinate to Fe
II
. From a 
thermodynamic standpoint, the potential of the Fe
III/II
 redox pair would shift negatively 
upon coordination to iron(III) while a positive shift would be expected upon binding of 
 acceptor ligands to iron(II) due to the stabilization of the reduced state. Whether the 
negative shift is indeed observed upon coordination of imidazole and CN

 to Fe
III
, the 
binding to Fe
II
 virtually does not affect the redox potential in the case of CO and, most 
unexpected, shifts the potential negatively upon coordination to O2, where there are 
significant changes around heme. Our results, however, supports electronic properties of 
the heme are not only dependent on the immediate sixth ligand, but a combination of 
effects including heme distortion and propionate interactions. We can conclude, 
therefore, that new microenvironment created upon binding to the studied ligands 
strongly control the overall potential trend, which shown to be correlated to histidine 
kinase activity of ReFixL. 
 
 
 
Abbreviations: BjFixL, Bradyrhizobium japonicum FixL; ReFixL, Rhizobium etli 
FixL; deoxy-ReFixL, Fe
II
 unliganded FixL; ReFixL-O2, Fe
II
-O2 FixL; ReFixL-CO, Fe
II
-
CO FixL; met-ReFixL, Fe
III
 unliganded FixL; ReFixL-CN, Fe
III
-cyanide FixL; ReFixL-
imz, Fe
III
-imidazole FixL,; imz, imidazole; Fe
II
, protoporphyrin IX-Fe
II
 complex; Fe
III
, 
protoporphyrin IX-Fe
III
 complex; NHE, normal hydrogen electrode; PAS, Per, ARNT, 
and Sim proteins domain; GAF, cGMP-specific and stimulated phosphodiesterases, 
adenylate cyclases, and E. coli formate hydrogen lyase transcriptional activator domain; 
SCHIC, sensor containing heme instead of cobalamin domain; HNOB, heme-NO-
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binding domain; LBD, ligand binding domain for nuclear receptors; CooA, CO sensor 
transcriptional regulator. 
 
Acknowledgements 
I.C.N. Diógenes (# 304285/2014-5), E.H.S. Silva (# 312030/2015-0), L.G.F. Lopes 
(#303732/2014-8) and N. H. Felício are thankful to CNPq and CAPES for the grants 
and financial support. 
 
 
References 
[1] M.-A. Gilles-Gonzalez, The smallest biomolecules: diatomics and their 
interactions with heme proteins, 1st ed., Elsevier Science, 2007. 
[2] M.A. Gilles-Gonzalez, G. Gonzalez, Heme-based sensors: defining 
characteristics, recent developments, and regulatory hypotheses, J. Inorg. 
Biochem. 99 (2005) 1-22. 
[3] T. Shimizu, D. Huang, F. Yan, M. Stranava, M. Bartosova, V. Fojtíková, M. 
Martínková, Gaseous O2, NO, and CO in signal transduction: structure and 
function relationships of heme-based gas sensors and heme-redox sensors, Chem. 
Rev. 115 (2015) 6491-6533. 
[4] M. Martínková, K. Kitanishi, T. Shimizu, Heme-based globin-coupled oxygen 
sensors: linking oxygen binding to functional regulation of diguanylate cyclase, 
histidine kinase, and methyl-accepting chemotaxis, J. Biol. Chem. 288 (2013) 
27702-27711. 
[5] M.-A. Gilles-Gonzalez, G.S. Ditta, D.R. Helinski, A hemoprotein with kinase 
activity encoded by the oxygen sensor of rhizobium meliloti, Nature 350 (1991) 
170-172. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
25 
 
[6] M.-A. Gilles-Gonzalez, A.I. Caceres, E.H.S. Sousa, D.R. Tomchick, C. 
Brautigam, C. Gonzalez, M. Machius, A proximal arginine R206 participates in 
switching of the bradyrhizobium japonicum FixL oxygen sensor, J. Mol. Biol. 360 
(2006) 80-89. 
[7] C.M. Dunham, E.M. Dioum, J.R. Tuckerman, G. Gonzalez, W.G. Scott, M.-A. 
Gilles-Gonzalez, A distal arginine in oxygen-sensing heme-PAS domains is 
essential to ligand binding, signal transduction, and structure, Biochemistry 42 
(2003) 7701-7708. 
[8] J.R. Tuckerman, G. Gonzalez, E.M. Dioum, M.-A. Gilles-Gonzalez, Ligand and 
oxidation-state specific regulation of the heme-based oxygen sensor FixL from 
Sinorhizobium meliloti, Biochemistry 41 (2002) 6170-6177. 
[9] J.R. Tuckerman, G. Gonzalez, M.-A. Gilles-Gonzalez, Complexation precedes 
phosphorylation for two-component regulatory system FixL/FixJ of 
Sinorhizobium meliloti, J. Mol. Biol. 308 (2001) 449-455. 
[10] E.H.S. Sousa, G. Gonzalez, M.-A. Gilles-Gonzalez, Oxygen blocks the reaction of 
the FixL−FixJ complex with ATP but does not influence binding of FixJ or ATP 
to FixL, Biochemistry 44 (2005) 15359-15365. 
[11] E.H.S. Sousa, J.R. Tuckerman, A.C.S. Gondim, G. Gonzalez, M.-A. Gilles-
Gonzalez, Signal transduction and phosphoryl transfer by a FixL hybrid kinase 
with low oxygen affinity: importance of the vicinal PAS domain and receiver 
aspartate, Biochemistry 52 (2013) 456-465. 
[12] E.H.S. Sousa, J.R. Tuckerman, G. Gonzalez, M.-A. Gilles-Gonzalez, A memory 
of oxygen binding explains the dose response of the heme-based sensor FixL, 
Biochemistry 46 (2007) 6249-6257. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
26 
 
[13] M. Mukai, K. Nakamura, H. Nakamura, T. Iizuka, Y. Shiro, Roles of Ile209 and 
Ile210 on the heme pocket structure and regulation of histidine kinase activity of 
oxygen sensor FixL from Rhizobium meliloti, Biochemistry 39 (2000) 13810-
13816. 
[14] J. Key, V. Šrajer, R. Pahl, K. Moffat, Time-resolved crystallographic studies of 
the heme domain of the oxygen sensor FixL:  structural dynamics of ligand 
rebinding and their relation to signal transduction, Biochemistry 46 (2007) 4706-
4715. 
[15] M.-A. Gilles-Gonzalez, G. Gonzalez, Regulation of the kinase activity of heme 
protein FixL from the two-component system FixL/FixJ of Rhizobium meliloti, J. 
Biol. Chem. 268 (1993) 16293-16297. 
[16] K.R. Rodgers, G.S. Lukat-Rodgers, Insights into heme-based O2 sensing from 
structure–function relationships in the FixL proteins, J. Inorg. Biochem. 99 (2005) 
963-977. 
[17] C. Olea, E.M. Boon, P. Pellicena, J. Kuriyan, M.A. Marletta, Probing the function 
of heme distortion in the H-NOX family, ACS Chem. Biol. 3 (2008) 703-710. 
[18] V. Balland, L. Bouzhir-Sima, E. Anxolabéhère-Mallart, A. Boussac, M.H. Vos, U. 
Liebl, T.A. Mattioli, Functional implications of the propionate 7−Arginine 220 
interaction in the FixLH oxygen sensor from Bradyrhizobium japonicum, 
Biochemistry 45 (2006) 2072-2084. 
[19] Y. Sasakura, S. Hirata, S. Sugiyama, S. Suzuki, S. Taguchi, M. Watanabe, T. 
Matsui, I. Sagami, T. Shimizu, Characterization of a direct oxygen sensor heme 
protein from Escherichia coli: effects of the heme redox states and mutations at 
the heme-binding site on catalysis and structure, J. Biol. Chem. 277 (2002) 23821-
23827. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
27 
 
[20] K. Kitanishi, K. Kobayashi, Y. Kawamura, I. Ishigami, T. Ogura, K. Nakajima, J. 
Igarashi, A. Tanaka, T. Shimizu, Important roles of Tyr43 at the putative heme 
distal side in the oxygen recognition and stability of the Fe(II)−O2 complex of 
YddV, a globin-coupled heme-based oxygen sensor diguanylate cyclase, 
Biochemistry 49 (2010) 10381-10393. 
[21] M.L. Fultz, R.A. Durst, Mediator compounds for the electrochemical study of 
biological redox systems: a compilation, Anal. Chim. Acta 140 (1982) 1-18. 
[22] I.I. Creaser, J.M. Harrowfield, A.J. Herlt, A.M. Sargeson, J. Springborg, R.J. 
Geue, M.R. Snow, Sepulchrate: a macrobicyclic nitrogen cage for metal ions, J.  
Am. Chem. Soc. 99 (1977) 3181-3182. 
[23] J.I. Bruce, L.R. Gahan, T.W. Hambley, R. Stranger, Synthesis, structure, and 
spectroscopy of encapsulated complexes of cobalt(III) derived from the ligand 5-
methyl-5-(4-amino-2-thiabutyl)-3,7-diazanonane-1,9-diamine (N5S), Inorg. 
Chem. 32 (1993) 5997-6002. 
[24] T.M. Donlevy, L.R. Gahan, T.W. Hambley, R. Stranger, Synthesis and 
spectroscopic properties of the encapsulated cobalt(III) complexes derived from 
the unsymmetrically substituted ligand 5-methyl-5-(4-amino-2-azabutyl)-3,7-
dithianonane-1,9-diamine (N4S2), Inorg. Chem. 31 (1992) 4376-4382. 
[25] P.V. Bernhardt, A.M.T. Bygott, R.J. Geue, A.J. Hendry, B.R. Korybut-
Daszkiewicz, P.A. Lay, J.R. Pladziewicz, A.M. Sargeson, A.C. Willis, 
Stabilization of cobalt cage conformers in the solid state and solution, Inorg. 
Chem. 33 (1994) 4553-4561. 
[26] P.V. Bernhardt, G.A. Lawrance, T.W. Hambley, 6,13-Diamino-6,13-dimethyl-
1,4,8,11-tetra-azacyclotetradecane, L7, a new, potentially sexidentate polyamine 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
28 
 
ligand. Variable coordination to Cobalt (III) and crystal structure of the complex 
[Co(L7)]Cl2[ClO4], J. Chem. Soc., Dalton Trans. (1989) 1059-1065. 
[27] R.J. Geue, T.W. Hambley, J.M. Harrowfield, A.M. Sargeson, M.R. Snow, Metal 
ion encapsulation: cobalt cages derived from polyamines, formaldehyde, and 
nitromethane, J.  Am. Chem. Soc. 106 (1984) 5478-5488. 
[28] M. Maeder, P. King, ReactLab REDOX, Jplus Consulting Pty Ltd, Perth, Western 
Australia, 2016. 
[29] M. Maeder, P. King, ReactLab Kinetics,Vol. 1.1, Jplus Consulting Pty Ltd, Perth, 
Western Australia, 2012. 
[30] P.V. Bernhardt, K.-I. Chen, P.C. Sharpe, Transition metal complexes as mediator-
titrants in protein redox potentiometry, J. Biol. Inorg. Chem. 11 (2006) 930-936. 
[31] M.-A. Gilles-Gonzalez,, G. Gonzalez, M.F. Perutz, L. Kiger, M.C. Marden, C. 
Poyart, Heme-based sensors, exemplified by the kinase FixL, are a new class of 
heme protein with distinctive ligand-binding and autoxidation, Biochemistry 33 
(1994) 8067-8073. 
[32] M.-A. Gilles-Gonzalez, G. Gonzalez, M.F. Perutz, Kinase-activity of oxygen 
sensor FixL depends on the spin-state of its heme iron, Biochemistry 34 (1995) 
232-236. 
[33] J.R. Tuckerman, G. Gonzalez, E.H.S. Sousa, X. Wan, J.A. Saito, M. Alam, M.-A. 
Gilles-Gonzalez, An oxygen-sensing diguanylate cyclase and phosphodiesterase 
couple for c-di-GMP control, Biochemistry 48 (2009) 9764-9774. 
[34] V.M. Delgado-Nixon, G. Gonzalez, M.-A. Gilles-Gonzalez, Dos, a heme-binding 
PAS Protein from Escherichia coli, is a direct oxygen sensor, Biochemistry 39 
(2000) 2685-2691. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
29 
 
[35] S. Hirata, T. Matsui, Y. Sasakura, S. Sugiyama, T. Yoshimura, I. Sagami, T. 
Shimizu, Characterization of Met95 mutants of a heme-regulated 
phosphodiesterase from Escherichia coli, Eur. J. Biochem. 270 (2003) 4771-4779. 
[36] Y. Ishitsuka, Y. Araki, A. Tanaka, J. Igarashi, O. Ito, T. Shimizu, Arg97 at the 
heme-distal side of the isolated heme-bound PAS domain of a heme-based oxygen 
sensor from Escherichia coli (Ec DOS) plays critical roles in autoxidation and 
binding to gases, particularly O2, Biochemistry 47 (2008) 8874-8884. 
[37] B.G. Fritz, X. Hu, J.L. Brailey, R.E. Berry, F.A. Walker, W.R. Montfort, 
Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta, 
Biochemistry 50 (2011) 5813-5815. 
[38] R. Makino, S.-y. Park, E. Obayashi, T. Iizuka, H. Hori, Y. Shiro, Oxygen binding 
and redox properties of the heme in soluble guanylate cyclase: implications for the 
mechanism of ligand discrimination, J. Biol. Chem. 286 (2011) 15678-15687. 
[39] S. Yoshioka, K. Kobayashi, H. Yoshimura, T. Uchida, T. Kitagawa, S. Aono, 
Biophysical properties of a c-type heme in chemotaxis signal transducer protein 
DcrA, Biochemistry 44 (2005) 15406-15413. 
[40] P.R. Pokkuluri, M. Pessanha, Y.Y. Londer, S.J. Wood, N.E.C. Duke, R. Wilton, 
T. Catarino, C.A. Salgueiro, M. Schiffer, Structures and solution properties of two 
novel periplasmic sensor domains with c-type heme from chemotaxis proteins of 
geobacter sulfurreducens: implications for signal transduction, J. Mol. Biol. 377 
(2008) 1498-1517. 
[41] B.C. King, F.M. Hawkridge, B.M. Hoffman, Electrochemical studies of 
cyanometmyoglobin and metmyoglobin: implications for long-range electron 
transfer in proteins, J. Am. Chem. Soc. 114 (1992) 10603-10608. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
30 
 
[42] D.L. Johnson, B.C. Lewis, D.J. Elliot, J.O. Miners, L.L. Martin, Electrochemical 
characterisation of the human cytochrome P450 CYP2C9, Biochem. Pharmacol. 
69 (2005) 1533-1541. 
[43] A.B. Cowley, M.L. Kennedy, S. Silchenko, G.S. Lukat-Rodgers, K.R. Rodgers, 
D.R. Benson, Insight into heme protein redox potential control and functional 
aspects of six-coordinate ligand-sensing heme proteins from studies of synthetic 
heme peptides, Inorg. Chem. 45 (2006) 9985-10001. 
[44] H.M. Marques, I. Cukrowski, P.R. Vashi, Coordination of weak field ligands by 
N-acetylmicroperoxidase-8 (NAcMP8), a ferric haempeptide from cytochrome c, 
and the influence of the axial ligand on the reduction potential of complexes of 
NAcMP8, J. Chem. Soc., Dalton Trans. (2000) 1335-1342. 
[45] W.C. Winkler, G. Gonzalez, J.B. Wittenberg, R. Hille, N. Dakappagari, A. Jacob, 
L.A. Gonzalez, M.-A. Gilles-Gonzalez, Nonsteric factors dominate binding of 
nitric oxide, azide, imidazole, cyanide, and fluoride to the rhizobial heme-based 
oxygen sensor FixL, Chem. Biol. 3 (1996) 841-850. 
[46] J. Key, K. Moffat, Crystal structures of deoxy and CO-Bound BjFixLH reveal 
details of ligand recognition and signaling, Biochemistry 44 (2005) 4627-4635. 
[47] B. Hao, C. Isaza, J. Arndt, M. Soltis, M.K. Chan, Structure-based mechanism of 
O2 sensing and ligand discrimination by the FixL heme domain of 
Bradyrhizobium japonicum, Biochemistry 41 (2002) 12952-12958. 
[48] W. Gong, B. Hao, M.K. Chan, New mechanistic insights from structural studies 
of the oxygen-sensing domain of Bradyrhizobium japonicum FixL, Biochemistry 
39 (2000) 3955-3962. 
[49] H. Miyatake, M. Mukai, S.-Y. Park, S.-i. Adachi, K. Tamura, H. Nakamura, K. 
Nakamura, T. Tsuchiya, T. Iizuka, Y. Shiro, Sensory mechanism of oxygen sensor 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
31 
 
FixL from Rhizobium meliloti: crystallographic, mutagenesis and resonance 
raman spectroscopic studies, J. Mol. Biol. 301 (2000) 415-431. 
[50] W. Gong, B. Hao, S.S. Mansy, G. Gonzalez, M.-A. Gilles-Gonzalez, M.K. Chan, 
Structure of a biological oxygen sensor: a new mechanism for heme-driven signal 
transduction, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15177-15182. 
[51] E. Lloyd, D.L. Burk, J.C. Ferrer, R. Maurus, J. Doran, P.R. Carey, G.D. Brayer, 
A.G. Mauk, Electrostatic modification of the active site of myoglobin:  
characterization of the proximal Ser92Asp variant, Biochemistry 35 (1996) 
11901-11912. 
[52] A.R. Lim, B.P. Sishta, A. Grant Mauk, Contribution of the heme propionate 
groups to the electron transfer and electrostatic properties of myoglobin, J. Inorg. 
Biochem. 100 (2006) 2017-2023. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
32 
 
Graphical abstract 
 
  
 
 
 
 
Graphical Abstract (synopsis) 
Midpoint potentials assigned to the Fe
III/II
 redox couple of the heme domain of FixL 
from Rhizobium etli (ReFixL) were determined for the unliganded state (+19 mV) and 
bounded to CO (+21 mV), O2 (51 mV), imidazole (57 mV) and CN

 (156 mV) and 
support a  correlation with the kinase activity. 
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Highlights 
 First time measured the electrochemical potential of a full-length FixL protein 
 Potentials were determined for Rhizobium etli FixL (ReFixL) bounded to 
different ligands 
 Surprisingly, oxygen bound ReFixL showed a negative potential shift of 70 mV 
 Electrochemical potentials showed a trend linked to the histidine-kinase activity 
